☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
New Facility
Pharming Receive EMA's Approval to Establish New Facility for Manufacturing Ruconest (conestat alfa)
January 21, 2020
Biocon Report the US FDA's Approval of sBLA for Fulphila (biosimilar- pegfilgrastim) Manufactured at its New Facility in Bengaluru
November 27, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.